Literature DB >> 25332625

Fanconi Anemia with MDS RAEB-2 Rapidly Progressing to AML in a 5-Year-Old Boy.

H Rama1, Devika Gupta1, Tathagata Chatterjee1, Srishti Gupta1.   

Abstract

Fanconi's Anemia is primarily an autosomal recessive genetic disorder characterized by congenital abnormalities, defective haematopoiesis leading to bone marrow failure and increased risk of development of Myelodysplastic syndrome, acute myeloid leukemia and solid tumours. Chromosomal instability can be demonstrated by breakage caused by alkylating agents and forms the basis of diagnosis. Our patient presented with structural deformities associated with features of bone marrow failure in form of pancytopenia. Bone marrow analysis and flow cytometry done on aspirate was suggestive of MDS. He subsequently progressed to frank acute myeloid leukemia and succumbed to the illness. The case is being reported for its rarity especially, Fanconi's Anemia associated with monosomal karyotype (one monosomy plus one more structural abnormality).

Entities:  

Keywords:  AML; Chromosomal anomalies; Chromosomal breakage syndrome; Fanconi’s anemia

Year:  2014        PMID: 25332625      PMCID: PMC4192240          DOI: 10.1007/s12288-014-0424-y

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  9 in total

1.  Secular trends in outcomes for Fanconi anemia patients who receive transplants: implications for future studies.

Authors:  Philip S Rosenberg; Blanche P Alter; Gerard Socié; Eliane Gluckman
Journal:  Biol Blood Marrow Transplant       Date:  2005-09       Impact factor: 5.742

2.  Fanconi anemia diagnosis and the diepoxybutane (DEB) test.

Authors:  A D Auerbach
Journal:  Exp Hematol       Date:  1993-06       Impact factor: 3.084

Review 3.  Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AML.

Authors:  Andrzej Rochowski; Susan B Olson; Todd A Alonzo; Robert B Gerbing; Beverly J Lange; Blanche P Alter
Journal:  Pediatr Blood Cancer       Date:  2012-04-19       Impact factor: 3.167

Review 4.  Pathophysiology and management of inherited bone marrow failure syndromes.

Authors:  Akiko Shimamura; Blanche P Alter
Journal:  Blood Rev       Date:  2010-04-24       Impact factor: 8.250

Review 5.  Fanconi anaemia and leukaemia - clinical and molecular aspects.

Authors:  Marc Tischkowitz; Inderjeet Dokal
Journal:  Br J Haematol       Date:  2004-07       Impact factor: 6.998

Review 6.  Cancer in Fanconi anemia, 1927-2001.

Authors:  Blanche P Alter
Journal:  Cancer       Date:  2003-01-15       Impact factor: 6.860

7.  Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor.

Authors:  Holger Tönnies; Stefanie Huber; Jörn-Sven Kuhl; Antje Gerlach; Wolfram Ebell; Heidemarie Neitzel
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113

8.  A 20-year perspective on the International Fanconi Anemia Registry (IFAR).

Authors:  David I Kutler; Bhuvanesh Singh; Jaya Satagopan; Sat Dev Batish; Marianne Berwick; Philip F Giampietro; Helmut Hanenberg; Arleen D Auerbach
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

Review 9.  Gene therapy for fanconi anemia.

Authors:  James M Croop
Journal:  Curr Hematol Rep       Date:  2003-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.